Investment Q&A

• Knight Therapeutics Inc. (GUD)
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Peter and Team:
Do you feel a Democratic Presidential win would have short or long term affects on GUD's business model and share price?.
What is their overall exposure to US markets.

Thanks as always

Phil

Upvote 0

Read Answer Asked by Phil on September 06, 2016

Q: Hi Peter, Ryan and Team,

I own shares of CTH. In your opinion, would it be better to sell at around $52 or wait?

Thank you for your insight.

Upvote 0

Read Answer Asked by Michel L on September 05, 2016

• Merus Labs International Inc. (MSL)
  • View MSL Profile
  • View Questions on MSL

Q: Insider buying after a big drop a good sign ?

Upvote 0

Read Answer Asked by j stuart on September 02, 2016

• Knight Therapeutics Inc. (GUD)
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD
• Crescita Therapeutics Inc. (CTX)
  • View CTX Profile
  • View Questions on CTX

Q: I would like your Opinions in regard to this mornings news with these 3 companies. I have held NRI for a very long time. CTX was a recent spin-off. No GUD shares at the moment. Thanks, Catherine

Upvote 0

Read Answer Asked by Catherine on September 01, 2016

• Gilead Sciences Inc. (GILD)
  • View GILD Profile
  • View Questions on GILD

Q: I own some GILD and am looking to add to it due to its drop in share price which I can't seem to pinpoint why. Do you believe this is a stock to be adding to, (assuming weighting is still in line). If not, any other recommendations for US value stocks (any sector)
Thanks as always

Upvote 0

Read Answer Asked by Jim on August 30, 2016

• Concordia Healthcare (CXR)
  • View CXR Profile
  • View Questions on CXR

Q: Hi Guys
I asked your opinion on Concordia last week,thank you for your response.I'd like to be a little more specific.
It looks like one of the major reasons for their loss is an "unusual expense" of $588.4 million.Could you explain what it is and if it will repeat.
Thanks
Michael

Upvote 0

Read Answer Asked by Michael on August 29, 2016

• iShares Global Healthcare ETF (IXJ)
  • View IXJ Profile
  • View Questions on IXJ

Q: My advisor has recommended switching from Pfizer to a global diversified
healthcare ETF-iXJ.Is this reasonable in view of the fact that I own
nothing in the global market at all?

Upvote 0

Read Answer Asked by Sam on August 26, 2016

• BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH)
  • View ZUH Profile
  • View Questions on ZUH
• Harvest Healthcare Leaders Income ETF (HHL)
  • View HHL Profile
  • View Questions on HHL

Q: Please comment on these income funds, including the effect of management expenses.

Upvote 0

Read Answer Asked by James on August 26, 2016

• Savaria Corporation (SIS)
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: I am up >60% for savaria and was wondering if it is a good idea to take partial profits?

Or is there an optimum time to take partial profits?

Thank you,
Andrew

Upvote 0

Read Answer Asked by Andrew on August 25, 2016

• Liminal BioSciences Inc. (LMNL)
  • View LMNL Profile
  • View Questions on LMNL

Q: I would appreciate your comments on PLI's announcement this morning that it plans to acquire all of the shares of Telesta Therapeutics. Also is private equity or a large controlling shareholder behind PLI? In thie press release management exudes a lot of confidence about the future and it is hard to assess whether their confidence is misplaced.

Thank you, Peter

Upvote 0

Read Answer Asked by Peter on August 24, 2016

• Protech Home Medical Corp. (PTQ)
  • View PTQ Profile
  • View Questions on PTQ

Q: Hello,

PHM released Q3 financials this morning. I'd appreciate your analysis of the results at your convenience.

Thanks,

Francesco

Upvote 0

Read Answer Asked by francesco on August 24, 2016

• Liminal BioSciences Inc. (LMNL)
  • View LMNL Profile
  • View Questions on LMNL

Q: Hi guys,

Your reaction/thoughts (and the markets) to the purchase of Telesta.

Thanks,

Jim

Upvote 0

Read Answer Asked by jim on August 24, 2016

• Pfizer Inc. (PFE)
  • View PFE Profile
  • View Questions on PFE

Q: Is this a reasonable alternative to holding onto Phizer?

Upvote 0

Read Answer Asked by Sam on August 24, 2016

• Concordia Healthcare (CXR)
  • View CXR Profile
  • View Questions on CXR

Q: Hi Guys
What is your opinion about Concordia.A lot going on and stock price is down.Is it a good time to buy?
Thanks
Michael

Upvote 0

Read Answer Asked by Michael on August 24, 2016

• Amphastar Pharmaceuticals Inc. (AMPH)
  • View AMPH Profile
  • View Questions on AMPH

Q: Hi Peter your thoughts? Amphastar Pharmaceuticals (AMPH) It seems to be the maker of narcan for fentanyl overdoses - big problem these days. How's the company itself? Other suggestions due to generics now? Thanks.

Upvote 0

Read Answer Asked by Michael on August 23, 2016

• QHR Corporation (QHR)
  • View QHR Profile
  • View Questions on QHR

Q: Is the Loblaw offer to QHR a done deal? They say it's a definitive offer. Should I just offer my shares for sale at $3.10.

Upvote 0

Read Answer Asked by Clarence on August 23, 2016

• Medicure Inc. (MPH)
  • View MPH Profile
  • View Questions on MPH

Q: On Aug. 10th Medicure announced their results for the Qtr. and they looked good to me. What is your take on their results?
Gerry

Upvote 0

Read Answer Asked by Gerry on August 22, 2016

• Neovasc Inc. (NVCN)
  • View NVCN Profile
  • View Questions on NVCN

Q: As a member of 5iResearch I rec'd an email showing at list of companies with buys, strong buys, Holds, Sell, etc. When I do a search in 5i on this company I cannot find any information. And yet you are listing it as a strong Buy. Could you explain why this would be a good buy.

Upvote 0

Read Answer Asked by Ernie on August 22, 2016

• Miscellaneous (MISC)
  • View MISC Profile
  • View Questions on MISC
  • View Reports on MISC

Q: Cambrex had good momentum and did very well for a while. Any idea why it turned negative ? Should I hold or sell ?

Thank you very much,

Jacques

Upvote 0

Read Answer Asked by Jacques on August 22, 2016

• Protech Home Medical Corp. (PTQ)
  • View PTQ Profile
  • View Questions on PTQ

Q: Patient Home Monitoring announced they will hold a conference call on Aug 24th to review the Qtr results and update the market (not shareholders) on plans for 2016 and beyond. Participants will be the CEO and CSO. No mention of the new CFO they announced on June 29th. What's your read on why they wouldn't take this opportunity to formerly introduce the CFO to the market? Do you think this is because the results may be okay and the forward strategy is what they want the market to focus on?

Upvote 0

Read Answer Asked by Gordon on August 22, 2016